Daniel A. Haber

University of Nevada, Las Vegas — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

135h-index108.3kcitations529works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(118), Cancer Cells and Metastasis(107), Lung Cancer Treatments and Mutations(63), Renal and related cancers(58), DNA Repair Mechanisms(37)

Publications517 total

Data from Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition
2025Open Access
Supplementary Data from Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition
2025Open Access
Long-term empirical radiation detector calibration for airborne geophysical surveying
Journal of Environmental Radioactivity·2025Open Access
A Host-Protein Test for Differentiating Bacterial From Viral Infection: Diagnostic Accuracy in Elderly Patients
Journal of the American College of Emergency Physicians Open·2025Open Access
The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis.
PubMed·2025Open Access
Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications
Cancer Cell·2025· 21 citedOpen Access
Microfluidic Isolation and Molecular Characterization of Circulating Tumor Cells in Prostate Cancer
2025
CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitors
Proceedings of the National Academy of Sciences·2025Open Access
Abstract P2-01-17: Genomic predictors of response among patients with hormone receptor-positive (HR+)/HER2- metastatic breast cancer (MBC) receiving the AKT inhibitor (AKTi) ipatasertib combined w/ endocrine therapy & a CDK4/6 inhibitor (CDK4/6i) in TAKTIC trial
Clinical Cancer Research·2025
Abstract 257: The E3 ligase HECTD4 regulates COX-2 dependent tumor progression and metastasis
Cancer Research·2025
The E3 ligase HECTD4 regulates COX-2 dependent tumor progression and metastasis
2025· 1 citedOpen Access
Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates
2025· 3 citedOpen Access
AMS Radiological Survey of Pinyon Plain Mine
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)·2025Open Access
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
Nature Communications·2025· 20 citedOpen Access
Abstract A017: High-throughput microfluidic enrichment of circulating tumor cells from entire diagnostic leukapheresis for comprehensive liquid biopsy
Clinical Cancer Research·2024
Abstract IA005: Tumor cell-based liquid biopsy to characterize prostate cancer
Clinical Cancer Research·2024
Combination Diagnostics: Adding Blood-Based ctDNA Screening to Low-Dose CT Imaging for Early Detection of Lung Cancer
Cancer Discovery·2024· 1 cited
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors
Nature Cancer·2024· 14 citedOpen Access
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment
PLoS ONE·2024Open Access
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Cell·2024· 76 citedOpen Access
page 1 of 26Next →

Frequent Co-authors

Shyamala Maheswaran(16), Daphne W. Bell(14), Mehmet Toner(13), Lecia V. Sequist(12), Brian W. Brannigan(9), David T. Ting(9), Thomas J. Lynch(8), Jeffrey Settleman(8), Sridhar Ramaswamy(8), Shannon L. Stott(8), David T. Miyamoto(7), Min Yu(7), Ravi Kapur(7), Cyril H. Benes(6), Sreenath V. Sharma(6), Ben S. Wittner(6), Toshi Shioda(6), Dennis C. Sgroi(6), A. John Iafrate(5), Aditya Bardia(5)